13F HOLDINGS REPORT
Avidity Partners Management LP
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001791827-23-000002
Total Value
$4.62B
Positions
85
Other Managers
0
Confidential Omitted
No
Holdings (85)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 4,062,000 | $337.1M | 7.30% |
| 2 | ARGENX SE | ARGX | 625,000 | $236.8M | 5.13% |
| 3 | UNITED THERAPEUTICS CORP DEL | UTHR | 785,500 | $218.4M | 4.73% |
| 4 | NEUROCRINE BIOSCIENCES INC | NBIX | 1,780,000 | $212.6M | 4.61% |
| 5 | AKERO THERAPEUTICS INC | 00973Y108 | 3,825,000 | $209.6M | 4.54% |
| 6 | PROTHENA CORP PLC | PRTA | 2,953,000 | $177.9M | 3.85% |
| 7 | ARVINAS INC | ARVN | 4,950,000 | $169.3M | 3.67% |
| 8 | BOSTON SCIENTIFIC CORP | BSX | 3,256,700 | $150.7M | 3.26% |
| 9 | SYNDAX PHARMACEUTICALS INC | SNDX | 5,861,000 | $149.2M | 3.23% |
| 10 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 2,990,000 | $138.5M | 3.00% |
| 11 | SAREPTA THERAPEUTICS INC | SRPT | 1,055,000 | $136.7M | 2.96% |
| 12 | MADRIGAL PHARMACEUTICALS INC | MDGL | 430,000 | $124.8M | 2.70% |
| 13 | UNIVERSAL HLTH SVCS INC | 913903100 | 825,600 | $116.3M | 2.52% |
| 14 | JAZZ PHARMACEUTICALS PLC | JAZZ | 727,541 | $115.9M | 2.51% |
| 15 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 5,150,000 | $103.7M | 2.25% |
| 16 | ACADIA HEALTHCARE COMPANY IN | ACHC | 1,165,000 | $95.9M | 2.08% |
| 17 | SURGERY PARTNERS INC | SGRY | 3,112,000 | $86.7M | 1.88% |
| 18 | DEXCOM INC | DXCM | 756,800 | $85.7M | 1.86% |
| 19 | ASTRAZENECA PLC | AZN | 1,200,000 | $81.4M | 1.76% |
| 20 | LILLY ELI & CO | LLY | 217,000 | $79.4M | 1.72% |
| 21 | VAXCYTE INC | PCVX | 1,615,400 | $77.5M | 1.68% |
| 22 | AVIDITY BIOSCIENCES INC | 05370A108 | 3,275,000 | $72.7M | 1.57% |
| 23 | NATERA INC | NTRA | 1,798,900 | $72.3M | 1.57% |
| 24 | IDEAYA BIOSCIENCES INC | IDYA | 3,824,800 | $69.5M | 1.51% |
| 25 | IMMUNOCORE HLDGS PLC | IMCR | 1,154,000 | $65.9M | 1.43% |
| 26 | ALTIMMUNE INC | ALT | 3,990,000 | $65.6M | 1.42% |
| 27 | REVOLUTION MEDICINES INC | RVMDW | 2,475,000 | $59.0M | 1.28% |
| 28 | KARUNA THERAPEUTICS INC | 48576A100 | 299,000 | $58.8M | 1.27% |
| 29 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 1,375,000 | $55.8M | 1.21% |
| 30 | AXSOME THERAPEUTICS INC | AXSM | 670,000 | $51.7M | 1.12% |
| 31 | VERTEX PHARMACEUTICALS INC | VRTX | 172,000 | $49.7M | 1.08% |
| 32 | LEGEND BIOTECH CORP | LEGN | 970,000 | $48.4M | 1.05% |
| 33 | KEZAR LIFE SCIENCES INC | KZR | 6,782,400 | $47.7M | 1.03% |
| 34 | PLIANT THERAPEUTICS INC | PLRX | 2,240,400 | $43.3M | 0.94% |
| 35 | VENTYX BIOSCIENCES INC | 92332V107 | 1,285,000 | $42.1M | 0.91% |
| 36 | ICON PLC | ICLR | 215,000 | $41.8M | 0.90% |
| 37 | QUEST DIAGNOSTICS INC | DGX | 258,000 | $40.4M | 0.87% |
| 38 | BIO RAD LABS INC | 090572207 | 92,200 | $38.8M | 0.84% |
| 39 | BELLUS HEALTH INC NEW | 07987C204 | 4,599,998 | $37.8M | 0.82% |
| 40 | TENET HEALTHCARE CORP | THC | 717,300 | $35.0M | 0.76% |
| 41 | KARYOPHARM THERAPEUTICS INC | KPTI | 9,633,911 | $32.8M | 0.71% |
| 42 | BIONTECH SE | BNTX | 215,400 | $32.4M | 0.70% |
| 43 | VERVE THERAPEUTICS INC | 92539P101 | 1,565,000 | $30.3M | 0.66% |
| 44 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,527,087 | $29.9M | 0.65% |
| 45 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 504,000 | $26.7M | 0.58% |
| 46 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 1,755,000 | $26.0M | 0.56% |
| 47 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 204,000 | $22.4M | 0.49% |
| 48 | INTELLIA THERAPEUTICS INC | NTLA | 638,200 | $22.3M | 0.48% |
| 49 | VIR BIOTECHNOLOGY INC | VIR | 850,000 | $21.5M | 0.47% |
| 50 | PHATHOM PHARMACEUTICALS INC | PHAT | 1,900,000 | $21.3M | 0.46% |
| 51 | BIOHAVEN LTD | BHVN | 1,492,000 | $20.7M | 0.45% |
| 52 | CYTOKINETICS INC | CYTK | 420,700 | $19.3M | 0.42% |
| 53 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 1,126,000 | $18.5M | 0.40% |
| 54 | CARIBOU BIOSCIENCES INC | CRBU | 2,882,600 | $18.1M | 0.39% |
| 55 | IVERIC BIO INC | 46583P102 | 838,407 | $18.0M | 0.39% |
| 56 | POINT BIOPHARMA GLOBAL INC | 730541109 | 2,432,400 | $17.7M | 0.38% |
| 57 | NANOSTRING TECHNOLOGIES INC | 63009R109 | 2,057,200 | $16.4M | 0.36% |
| 58 | TWIST BIOSCIENCE CORP | TWST | 611,000 | $14.5M | 0.32% |
| 59 | BIOATLA INC | BCAB | 1,260,000 | $10.4M | 0.23% |
| 60 | COMPASS THERAPEUTICS INC | CMPX | 2,000,000 | $10.1M | 0.22% |
| 61 | SANGAMO THERAPEUTICS INC | SGMO | 2,748,300 | $8.6M | 0.19% |
| 62 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 1,028,200 | $7.6M | 0.16% |
| 63 | KINNATE BIOPHARMA INC | 49705R105 | 1,212,700 | $7.4M | 0.16% |
| 64 | AN2 THERAPEUTICS INC | ANTX | 743,600 | $7.1M | 0.15% |
| 65 | CENTURY THERAPEUTICS INC | IPSC | 1,303,600 | $6.7M | 0.14% |
| 66 | MEDICUS SCIENCES ACQUISITION | G5960S108 | 520,000 | $5.2M | 0.11% |
| 67 | GRAPHITE BIO INC | 38870X104 | 1,575,000 | $5.2M | 0.11% |
| 68 | ARYA SCIENCES ACQU CORP IV | G31659108 | 500,000 | $5.0M | 0.11% |
| 69 | PANACEA ACQUISITION CORP II | G6882C106 | 500,000 | $5.0M | 0.11% |
| 70 | ESSA PHARMA INC | 29668H708 | 1,855,400 | $4.7M | 0.10% |
| 71 | HEALTH SCIENCES ACQ CORP 2 | G4411D109 | 400,000 | $4.0M | 0.09% |
| 72 | SYROS PHARMACEUTICALS INC | 87184Q206 | 900,000 | $3.2M | 0.07% |
| 73 | CYTEIR THERAPEUTICS INC | 23284P103 | 1,795,800 | $3.0M | 0.06% |
| 74 | CAREMAX INC | 14171W103 | 755,329 | $2.8M | 0.06% |
| 75 | SOCIAL CAP SUVRETTA HLDS CRP | G8253U103 | 200,000 | $2.0M | 0.04% |
| 76 | SOCIAL CAP SUVRETTA HLDS CP | G8253Y105 | 200,000 | $2.0M | 0.04% |
| 77 | SCYNEXIS INC | SCYX | 1,140,600 | $1.8M | 0.04% |
| 78 | HYPERFINE INC | HYPR | 1,503,754 | $1.3M | 0.03% |
| 79 | FATE THERAPEUTICS INC | FATE | 104,653 | $1.1M | 0.02% |
| 80 | ZAI LAB LTD | ZLAB | 31,309 | $961,186 | 0.02% |
| 81 | COLLEGIUM PHARMACEUTICAL INC | COLL | 37,898 | $879,234 | 0.02% |
| 82 | AC IMMUNE SA | ACIU | 325,400 | $663,816 | 0.01% |
| 83 | REUNION NEUROSCIENCE INC | 76134G103 | 560,300 | $504,270 | 0.01% |
| 84 | NUVATION BIO INC | NUVB | 99,999 | $14,450 | 0.00% |
| 85 | MEDICUS SCIENCES ACQUISITION | G5960S124 | 57,770 | $5,199 | 0.00% |